Abstract
Objective
The purpose of this study is to evaluate the relationship between plasma high-sensitivity C-reactive protein (hs-CRP), atrial natriuretic peptides (ANP), N-terminal-pro-brain natriuretic peptide (NT-proBNP) levels, and the risk and recurrence of atrial fibrillation (AF) after pulmonary vein isolation (PVI) in patients with paroxysmal atrial fibrillation (PAF).
Methods
Plasma ANP, NT-proBNP, and hs-CRP levels were measured before and 3 months after PVI in 33 patients with PAF and 30 control participants.
Results
(1) NT-proBNP levels at baseline were significantly elevated in subjects with PAF compared with control subjects (296.8 ± 272.1 vs. 80.8 ± 69.1 pg/ml), but ANP and hs-CRP levels were normal; NT-proBNP levels normalized 3 months after PVI, but ANP and hs-CRP levels did not change significantly; NT-proBNP levels at baseline in the recurrent group were markedly higher than those in the nonrecurrent AF group (572.7 ± 234.2 vs. 176.8 ± 188.7 pg/ml). (2) Cox stepwise multivariate analysis demonstrated that only elevated NT-proBNP level at baseline was an independent predictor of AF recurrence (p < 0.001) after PVI among 13 variables, such as echocardiographic parameters, plasma ANP, NT-proBNP, and hs-CRP levels. A cutoff value of NT-proBNP ≥ 423.2 pg/ml was a significant risk factor for AF recurrence (p = 0.002).
Conclusions
Elevated NT-proBNP level at baseline, but not ANP and hs-CRP, is a sensitive biomarker for early predicting AF recurrence in patients with PAF.
Similar content being viewed by others
References
Lo, L. W., & Chen, S. A. (2009). Developments and recent advances in catheter ablation of paroxysmal atrial fibrillation. Future Cardiology, 5, 557–565.
Goetze, J. P., Friis-Hansen, L., Rehfeld, J. F., Nilsson, B., & Svendsen, J. H. (2006). Atrial secretion of B-type natriuretic peptide. European Heart Journal, 27, 1648–1650.
Ellinor, P. T., Low, A. F., Patton, K. K., Shea, M. A., & Macrae, C. A. (2005). Discordant atrial natriuretic peptide and brain natriuretic peptide levels in lone atrial fibrillation. Journal of the American College of Cardiology, 45, 82–86.
Shin, D. I., Jaekel, K., Schley, P., et al. (2005). Plasma levels of NT-pro-BNP in patients with atrial fibrillation before and after electrical cardioversion. Zeitschrift für Kardiologie, 94, 795–800.
Kallergis, E. M., Manios, E. G., Kanoupakis, E. M., et al. (2010). Effect of sinus rhythm restoration after electrical cardioversion on apelin and brain natriuretic peptide prohormone levels in patients with persistent atrial fibrillation. The American Journal of Cardiology, 105, 90–94.
Yamada, T., Murakami, Y., Okada, T., et al. (2006). Plasma atrial natriuretic peptide and brain natriuretic peptide levels after radiofrequency catheter ablation of atrial fibrillation. The American Journal of Cardiology, 97, 1741–1744.
Malouf, J. F., Kanagala, R., Al, A. F., et al. (2005). High sensitivity C-reactive protein: a novel predictor for recurrence of atrial fibrillation after successful cardioversion. Journal of the American College of Cardiology, 46, 1284–1287.
Wazni, O., Martin, D. O., Marrouche, N. F., et al. (2005). C reactive protein concentration and recurrence of atrial fibrillation after electrical cardioversion. Heart, 91, 1303–1305.
Casaclang-Verzosa, G., Gersh, B. J., & Tsang, T. S. (2008). Structural and functional remodeling of the left atrium: clinical and therapeutic implications for atrial fibrillation. Journal of the American College of Cardiology, 51, 1–11.
Wazni, O. M., Marrouche, N. F., Martin, D. O., et al. (2005). Radiofrequency ablation vs antiarrhythmic drugs as first-line treatment of symptomatic atrial fibrillation: a randomized trial. Journal of the American Medical Association, 293, 2634–2640.
Burke, M. A., & Cotts, W. G. (2007). Interpretation of B-type natriuretic peptide in cardiac disease and other comorbid conditions. Heart Failure Reviews, 12, 23–36.
Silver, M. A., Maisel, A., Yancy, C. W., et al. (2004). BNP Consensus Panel 2004: A clinical approach for the diagnostic, prognostic, screening, treatment monitoring, and therapeutic roles of natriuretic peptides in cardiovascular diseases. Congestive Heart Failure, 10, 1–30.
Inoue, S., Murakami, Y., Sano, K., Katoh, H., & Shimada, T. (2000). Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation. Journal of Cardiac Failure, 6, 92–96.
Wokhlu, A., Hodge, D. O., Monahan, K. H., et al. (2010). Long-term outcome of atrial fibrillation ablation: impact and predictors of very late recurrence. Journal of Cardiovascular Electrophysiology, 21, 1071–1078.
Oral, H., Pappone, C., Chugh, A., et al. (2006). Circumferential pulmonary-vein ablation for chronic atrial fibrillation. The New England Journal of Medicine, 354, 934–941.
Shin, D. I., Deneke, T., Gorr, E., et al. (2009). Predicting successful pulmonary vein isolation in patients with atrial fibrillation by brain natriuretic peptide plasma levels. Indian Pacing and Electrophysiology Journal, 9, 241–246.
Li, J., & Wang, L. (2006). B-type natriuretic peptide levels in patients with paroxysmal lone atrial fibrillation. Heart and Vessels, 21, 137–140.
Lee, S. H., Jung, J. H., Choi, S. H., et al. (2006). Determinants of brain natriuretic peptide levels in patients with lone atrial fibrillation. Circulation Journal, 70, 100–104.
Chung, M. K., Martin, D. O., Sprecher, D., et al. (2001). C-reactive protein elevation in patients with atrial arrhythmias: inflammatory mechanisms and persistence of atrial fibrillation. Circulation, 104, 2886–2891.
Psychari, S. N., Apostolou, T. S., Sinos, L., Hamodraka, E., Liakos, G., & Kremastinos, D. T. (2005). Relation of elevated C-reactive protein and interleukin-6 levels to left atrial size and duration of episodes in patients with atrial fibrillation. The American Journal of Cardiology, 95, 764–767.
Lin, Y. J., Tsao, H. M., Chang, S. L., et al. (2010). Prognostic implications of the high-sensitive C-reactive protein in the catheter ablation of atrial fibrillation. The American Journal of Cardiology, 105, 495–501.
Letsas, K. P., Weber, R., Burkle, G., et al. (2009). Pre-ablative predictors of atrial fibrillation recurrence following pulmonary vein isolation: the potential role of inflammation. Europace, 11, 158–163.
Buob, A., Jung, J., Siaplaouras, S., Neuberger, H. R., & Mewis, C. (2006). Discordant regulation of CRP and NT-proBNP plasma levels after electrical cardioversion of persistent atrial fibrillation. Pacing and Clinical Electrophysiology, 29, 559–563.
Korantzopoulos, P., Kolettis, T. M., Kountouris, E., Siogas, K., & Goudevenos, J. A. (2005). Variation of inflammatory indexes after electrical cardioversion of persistent atrial fibrillation. Is there an association with early recurrence rates? International Journal of Clinical Practice, 59, 881–885.
Cosgrave, J., Foley, J. B., Bahadur, K., Bennett, K., Crean, P., & Walsh, M. J. (2006). Inflammatory markers are not associated with outcomes following elective external cardioversion. International Journal of Cardiology, 110, 373–377.
Psychari, S. N., Chatzopoulos, D., Iliodromitis, E. K., Apostolou, T. S., & Kremastinos, D. T. (2011). C-reactive protein, interleukin 6, and N-terminal pro-brain natriuretic peptide following cardioversion of atrial fibrillation: is there a role of biomarkers in arrhythmia recurrence? Angiology, 62, 310–316.
Ellinor, P. T., Low, A., Patton, K. K., Shea, M. A., & MacRae, C. A. (2006). C-reactive protein in lone atrial fibrillation. The American Journal of Cardiology, 97, 1346–1350.
Rizos, I., Rigopoulos, A. G., Kalogeropoulos, A. S., et al. (2010). Hypertension and paroxysmal atrial fibrillation: a novel predictive role of high sensitivity C-reactive protein in cardioversion and long-term recurrence. Journal of Human Hypertension, 24, 447–457.
Acknowledgments
This study was supported by Chongqing Atrial Fibrillation Research and Therapeutic Center.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Fan, J., Cao, H., Su, L. et al. NT-proBNP, but not ANP and C-reactive protein, is predictive of paroxysmal atrial fibrillation in patients undergoing pulmonary vein isolation. J Interv Card Electrophysiol 33, 93–100 (2012). https://doi.org/10.1007/s10840-011-9606-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10840-011-9606-9